{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:58:36Z","timestamp":1789725516561,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T00:00:00Z","timestamp":1181088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T00:00:00Z","timestamp":1181088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s10096-007-0321-5","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T12:23:01Z","timestamp":1181046181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae"],"prefix":"10.1007","volume":"26","author":[{"given":"S.","family":"Riedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Beekmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. P.","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garcia-de-Lomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Goosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V.","family":"Doern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,6]]},"reference":[{"key":"321_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/45.2.191","volume":"45","author":"D Felmingham","year":"2000","unstructured":"Felmingham D, Gr\u00fcneberg RN, the Alexander Project Group (2000) The Alexander project 1996\u20131997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. JAC 45:191\u2013203","journal-title":"JAC"},{"key":"321_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","volume":"52","author":"MR Jacobs","year":"2003","unstructured":"Jacobs MR, Felmingham D, Appelbaum PC, Gr\u00fcneberg RN et al (2003) The Alexander project 1998\u20132002: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. JAC 52:229\u2013246","journal-title":"JAC"},{"key":"321_CR3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/CMR.3.2.171","volume":"3","author":"KP Klugman","year":"1990","unstructured":"Klugman KP (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3:171\u2013196","journal-title":"Clin Microbiol Rev"},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijantimicag.2004.09.016","volume":"25","author":"SE Beekmann","year":"2005","unstructured":"Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Doern GV (2005) Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A \u03b2-hemolytic streptococci in 2002\u20132003: results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 25:148\u2013156","journal-title":"Int J Antimicrob Agents"},{"key":"321_CR5","first-page":"590","volume":"9","author":"ME Jones","year":"2003","unstructured":"Jones ME, Blosser-Middleton RS, Critchley IA, Karlowsky JA, Thornsberry C, Sahm DF (2003) In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000\u20132001. CMI 9:590\u2013599","journal-title":"CMI"},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","volume":"45","author":"GV Doern","year":"2001","unstructured":"Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB (2001) Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995. Antimicrob Agents Chemother 45:1721\u20131729","journal-title":"Antimicrob Agents Chemother"},{"key":"321_CR7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","volume":"365","author":"H Goossens","year":"2005","unstructured":"Goossens H, Ferech M, Vander Stichele R, Elseviers M (2005) Outpatient antibiotic use in Europe and association with resistance: a cross national database study. Lancet 365:579\u2013587","journal-title":"Lancet"},{"key":"321_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JCM.40.1.159-164.2002","volume":"40","author":"C Garcia-Rey","year":"2002","unstructured":"Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R (2002) Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. JCM 40:159\u2013164","journal-title":"JCM"},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3201\/eid0803.010192","volume":"8","author":"SL Bronzwaer","year":"2002","unstructured":"Bronzwaer SL, Cars O, B\u00fccholz U (2002) European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278\u2013282","journal-title":"Emerg Infect Dis"},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/00006454-200012000-00011","volume":"19","author":"E Melander","year":"2000","unstructured":"Melander E, Ekdahl K, J\u00f6nsson G, M\u00f6lstad S (2000) Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 19:1172\u20131177","journal-title":"Pediatr Infect Dis J"},{"key":"321_CR11","unstructured":"Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing: approved standard and informational supplement M100-S16. CLSI, Wayne, PA"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJM199907223410403","volume":"341","author":"DK Chen","year":"1999","unstructured":"Chen DK, McGeer A, de Azavedo JC, Low DE (1999) Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada, Canadian Bacterial Surveillance Network. N Engl J Med 341:233\u2013239","journal-title":"N Engl J Med"},{"key":"321_CR13","unstructured":"World Health Organization (2004) Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. WHO, Oslo, Norway"},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/jac\/dkl188","volume":"58","author":"M Ferech","year":"2006","unstructured":"Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 58:401\u2013407","journal-title":"J Antimicrob Chemother"},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1365-2125.2004.02164.x","volume":"58","author":"R Vander Stichele","year":"2004","unstructured":"Vander Stichele R, Elseviers M, Ferech M et al (2004) European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 58:419\u2013428","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-007-0321-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0321-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T05:45:27Z","timestamp":1683870327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-007-0321-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,6]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0321-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,6]]},"assertion":[{"value":"6 June 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"485"}}